CERVANTES, FRANCISCO
 Distribuzione geografica
Continente #
NA - Nord America 43
EU - Europa 40
AS - Asia 12
Totale 95
Nazione #
US - Stati Uniti d'America 43
IE - Irlanda 11
RU - Federazione Russa 11
IT - Italia 8
SE - Svezia 6
JO - Giordania 4
CN - Cina 3
SG - Singapore 3
CH - Svizzera 2
HK - Hong Kong 2
DE - Germania 1
GB - Regno Unito 1
Totale 95
Città #
Dublin 11
Moscow 7
Altamura 6
Chandler 6
Lawrence 6
Ashburn 4
Boston 3
Princeton 3
Bern 2
Florence 2
San Diego 2
Shanghai 2
Andover 1
Bremen 1
Fairfield 1
Houston 1
London 1
Nantong 1
San Mateo 1
Singapore 1
Washington 1
Wilmington 1
Totale 64
Nome #
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study 39
Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: A phase 1b/2 dose-finding study 30
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide 29
Totale 98
Categoria #
all - tutte 659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 0 0 0 0 7 0 0 0 5
2022/202356 5 14 1 3 2 8 8 4 9 0 0 2
2023/202423 1 2 3 0 3 2 0 3 1 4 3 1
2024/20257 5 2 0 0 0 0 0 0 0 0 0 0
Totale 98